Akerna publishes half year review for the cannabis industry 2021

0
10

The report captures trends in the cannabis business, markets and consumer habits in 2021; shows an interesting category change in female product preferences.

DENVER, July 21, 2021 / PRNewswire / – Akerna (Nasdaq: KERN), an enterprise software leader, compliance technology leader, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today announced the Announced publication of its second annual semi-annual review.

Akerna publishes half-year review

This report sheds light on the state of the ever changing and emerging cannabis industry.

This report sheds light on the state of the ever changing and emerging cannabis industry. It delves deeply into cannabis operators, auxiliary cannabis, capital, new markets, consumer buying trends, and corporate social responsibility regarding the cannabis industry.

You can find the report here.

Sections on the Semi-Annual Review of the Cannabis Industry + Authors:

Introduction: Jessica Billingsley, Chief Executive Officer and Chairman of the Board, Akerna

Cannabis Markets: Trends and Forecasts: Scott Socio, Head of Corporate Development and Board Member, Akerna

States recognize the economic opportunity of cannabis: Sheri Springer, Director Service Sales, Akerna

Data Snapshot: Cannabis Consumption Spending and Trends: James Ahrendt, Business intelligence architect, Akerna

Cannabis and Corporate Social Responsibility: Missi Woolridge, Marketing and Community Engagement Specialist, Akerna

“We are carefully curating this data- and research-based report for anyone interested in better understanding the world’s fastest growing industry,” says Jessica Billingsley, Akerna managing director. “You will find this report useful as a business owner looking to make data-driven decisions, as an investor looking to learn more about the promising cannabis industry, or as a consumer looking to learn more about how the cannabis industry works to ensure safe deliveries of the products, that you consume. “

The story goes on

About Akerna

Akerna (Nasdaq: CORE) is an enterprise software company focused on serving the cannabis, hemp and CBD industries in compliance with the law. Based in Denver, Colorado, the company’s mission is to create the most transparent and responsible supply chain in the world by building a cannabis technology ecosystem that connects data points along the global cannabis supply chain from seeds to sales to an end in itself. Akerna was first launched in 2010 and has more than $ 20 billion in cannabis sales to date and was the first cannabis software company to be listed on the Nasdaq.

Akerna uses connected data and information to power the cannabis industry, empowering companies, governments, patients and consumers to make smart decisions. The company’s cornerstone technology, the MJ platform, the world’s leading infrastructure as a service platform, supports retailers, manufacturers, brands, distributors and growers. Akerna also offers a full package of professional consulting services and data analytics for businesses as well as Solo Sciences, MJ Freeway, Leaf Data Systems, Trellis, Ample Organics and Viridian Sciences.

Via MJ Freeway

MJ Freeway is more than software as a service. The flagship solution, MJ Platform, includes Platform Insights. Now operators, investors and regulators can access the largest and most statistically relevant database in the industry to make data-driven business decisions.

Platform Insights offers:

  • The greatest statistical relevance across countries

  • Normalized data (not bred from various different POS platforms)

  • Complete data on the cannabis supply chain

  • Business insights based on the category management methodology

Platform Insights can remove the guesswork and provide answers to questions like:

  • What is the gross margin on inventory?

  • Which SKUs should be carried?

  • How do shopping basket adjoinings influence discounting and retention strategies?

  • What does a medical market look like in the year

Click here More information about the MJ platform.

Forward-Looking Statements

Certain statements in this press release and all accompanying statements by management are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In this press release, the words “estimate”, “project”, “Expects”, “anticipates”, “predicts”, “planet”, “intends”, “believes”, “strives”, “can”, “will”, “should”, “future”, “propose” and variations These words or similar expressions (or the negative versions of such words or phrases) are intended to identify forward-looking statements, and such forward-looking statements include, but are not limited to, statements regarding the potential to add Barry Fischmann to the board of directors, subject to vote by shareholders at the company’s 2021 annual meeting, the potential benefits of adding Barry Fischmann to the board of directors, Akerna’s future business plans, Akerna’s potential business strengths in the marketplace, and any other statements that express Akerna’s management views on future business results or strategies. These forward-looking statements are not guarantees of future performance, conditions, or results and involve a number of significant known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond Akerna’s control and which could lead to actual results or results ( including, but not limited to, the results of Akerna’s contracts, strategic initiatives and business plans as described herein) differ materially from those discussed in the forward-looking statements. Important factors that could, among other things, affect actual results or results include (i) Akerna’s ability to see the anticipated benefits of a public company, (ii) competition, (iii) Akerna’s ability to grow and manage growth profitably, (iv ) Akerna’s ability to maintain relationships with customers and suppliers, and to retain its management and officers, (v) costs associated with a public company, (vi) changes in applicable law or regulation, (vii) Akerna’s ability to make acquisitions identify, complete, and incorporate, including Viridian, achieve and achieve anticipated synergies and operational efficiencies in connection with acquired companies, (viii) and other risks and uncertainties that may appear from time to time in Akerna’s filings with the Securities and Exchange Commission (Securities and Exchange Commission), including those therein listed under “Risk Factors”. Actual results, performance or achievements could differ materially and possibly adversely from projections and forward-looking statements and the assumptions on which they differ from forward-looking statements. No assurance can be given that the data contained herein in any way reflects future performance. You are cautioned not to rely on forward-looking statements as predictors of future performance, because forecast financial and other information is based on estimates and assumptions that inherently involve various significant risks, uncertainties, and other factors, many of which are beyond our control from Akerna. All information contained herein applies only as of the date of this information in the case of information about Akerna or the date of this information in the case of information from persons other than Akerna. Akerna assumes no obligation to update or revise the information contained herein. Projections and estimates regarding Akerna’s industry and end markets are based on sources believed to be reliable; However, no guarantee can be given that these forecasts and estimates will prove to be correct in whole or in part.

(PRNewsfoto / Akerna)

Cision

Cision

View original content to download multimedia: https://www.prnewswire.com/news-releases/akerna-releases-2021-cannabis-industry-mid-year-review-301338318.html

SOURCE Akerna